Imaging-defined residual risk after left atrial appendage occlusion: from device surveillance to antithrombotic and reintervention decision considerations - Quiz - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Residual Risk Assessment via Imaging Following Left Atrial Appendage Occlusion: Implications for Device Monitoring and Antithrombotic Therapy Decisions

  • By

  • Yuan Li

  • Yujian Liu

  • July 9, 2026

Share

Original Source(s)

Imaging-defined residual risk after left atrial appendage occlusion: from device surveillance to antithrombotic and reintervention decision considerations

  • by Yuan Li, Yujian Liu

  • July 9, 2026

Related Content

P2Y12 Inhibitors and Mortality in Patients Hospitalized With Intracerebral Hemorrhage

Pulse pressure and cardiometabolic disease progression: associations with incident multimorbidity and mortality in UK biobank

FDA Cites Manufacturing Issues for Cytisinicline

Application supported by Phase 3 smoking-cessation data and long-term safety findings.